However, with respect to headache and urinary tract infection, there was no significant difference in the safety of placebo, pregabalin, GM-1 ganglioside, venlafaxine XR, and fampridine on patients with SCI (Table 3). This evidence concerns the gene PPP1R3A and urinary tract infection.